Hale Güler Kara

6PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 12, 2026
Metabolomic Analysis of Intracellular Amino Acid Profile Differences Between Cisplatin-Resistant and Cisplatin- Sensitive CALU-1 Lung Cancer Cells.

|May 21, 2026
Effects of adjuvant propofol on antitumoral effects of carboplatin in experimental endometrial cancer: possible epigenetic associations.

|Apr 17, 2025
The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.

Hale Guler Kara, Eda Dogan, Vildan Bozok

|Jul 25, 2024
STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells.

Zafer Yildirim, Eda Doğan, Hale Güler Kara

|Oct 27, 2023
Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles.

Hale Guler Kara, Neslihan Pinar Ozates, Aycan Asik

|Jul 11, 2021
Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population.

Hale Güler Kara, Mehmet Emin Erdal, Senay Görücü Yılmaz

Pageof 1

Frequent Collaborators

1 joint publications

Mehmet Emin Erdal

1 joint publications

Senay Görücü Yılmaz

1 joint publications

Cem Şengül

1 joint publications

Ceyhan Balcı Şengül